StockData
Hinge Health, Inc. logo

Hinge Health, Inc. (HNGE) stock

HNGENYSEServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/30
$114.53+0.12 (+0.10%)

Close on Nov 18, 2026Market cap $9.24BP/E –Yield –

Hinge Health r&d expenses

Research and development expenses are spending on new products and technology.

Hinge Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $129.07M, down 63.1% year over year. For fiscal 2025 it was $368.14M, up 265.1% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$368.14M+265.1%
FY2024Dec 31, 2024$100.84M-8.4%
FY2023Dec 31, 2023$110.06M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$34.06M-87.8%
Q1 FY2026Mar 31, 2026$30.34M+29.1%
Q4 FY2025Dec 31, 2025$32.76M+46.4%
Q3 FY2025Sep 30, 2025$31.92M+34.2%
Q2 FY2025Jun 30, 2025$279.96M+1023.4%
Q1 FY2025Mar 31, 2025$23.50M–
Q4 FY2024Dec 31, 2024$22.37M–
Q3 FY2024Sep 30, 2024$23.79M–
Q2 FY2024Jun 30, 2024$24.92M–

More Hinge Health figures

See a number that looks wrong?